Related Experiment Video

Updated: Aug 3, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.5K

Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease

Raffaele Piccolo1, Lina Manzi1, Fiorenzo Simonetti1

  • 1Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.

Journal of Clinical Medicine
|April 13, 2023
PubMed

Insights

Multivessel coronary artery disease in ST-elevation myocardial infarction (STEMI) patients requires careful management of non-culprit lesions. Complete revascularization improves outcomes, but optimal timing and methods remain under investigation.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Multivessel disease affects about 50% of ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).
  • Complete revascularization in STEMI patients has been linked to improved clinical outcomes, including reduced risks of reinfarction and urgent revascularization.

Purpose of the Study:

  • To review the current evidence regarding the management of non-culprit lesions in STEMI patients.
  • To discuss the optimal timing and modality for revascularizing non-culprit lesions in STEMI patients, with or without cardiogenic shock.

Main Methods:

  • Review of randomized clinical trials and available evidence.
  • Analysis of different revascularization strategies: immediate versus staged procedures.
  • Evaluation of guidance modalities: angiography, functional assessment, and intracoronary imaging.

Main Results:

  • Complete revascularization in STEMI improves clinical outcomes.
  • The optimal timing (during index PCI or staged) and modality for non-culprit lesion revascularization are still debated.
  • Management strategies may differ in STEMI patients with cardiogenic shock.

Conclusions:

  • Evidence supports complete revascularization in STEMI patients.
  • Further research is needed to establish definitive guidelines for the timing and modality of non-culprit lesion treatment.
  • Personalized approaches considering patient factors and lesion characteristics are crucial.

Keywords:
STEMIcomplete revascularizationculprit lesionmultivessel diseasemyocardial infarctionnon-culprit coronary lesion

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

790
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
38
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15